Intellectual Property Strategy in Bioinformatics and Biochips

By Fernandez, Dennis; Chow, Mary | Santa Clara Computer & High Technology Law Journal, May 2003 | Go to article overview

Intellectual Property Strategy in Bioinformatics and Biochips


Fernandez, Dennis, Chow, Mary, Santa Clara Computer & High Technology Law Journal


I. INTRODUCTION

What are the fields of bioinformatics and biochips? These are relatively new disciplines that have gained much recognition in the past few years. Basically, bioinformatics is the convergence of analytical and computational tools with the discipline of biological research. This has vast influence in biological research, as numerous data that are collected through laboratory experiments can be organized and analyzed, and predictions can be made to reduce the time spent in finding cures for the causes and cures of diseases. Additionally, biochips pertain to primarily semiconductor-based devices used for biological or other healthcare-related applications.

The amount of data collected in biological research is tremendous especially in the area of genomics. On June 26, 2000, a group of scientists announced the completed survey of the human genome--the sum total of all the genes in each cell of the human body. (1) The genome is the entire genetic blueprint for a human being written in the alphabet of chemical compounds called nucleotides: adenine (A), guanine (G), cytosine (C), and thiamine (T). (2) A gene is the specific sequence of the nucleotides that tells the body how to create proteins that maintain cellular structure of the organism and direct the functions of the cell. (3) The human cell has some 100,000 genes that are specific sequences of DNA and the sum total of all units of nucleotides results in a mind-boggling 3.1 to 3.2 billion base pairs in the human genome. (4) However, only 3%-5% of the genome contains genes, which in turn produce four to five proteins. These few protein molecules control all of life's major functions. (5) Thus, computational technology is required in the sequencing of the database, the studying of the functions of the specific sequence (gene), and the management and dissemination of the genetic information.

With the potential pay-off of finding a blockbuster drug or treatment, a copious amount of funding, both private and public, has gone into the development of bioinformatic tools as well as related biochip applications in the genomic space. With all the money going into these bioinformatic and biochip companies, these companies need to protect their technology. In 1999 alone, for example, 289,448 patent applications were filed in the bioinformatic field and the United States Patent and Trademark Office (USPTO) has created working groups to deal with the influx of bioinformatic applications. (6) Although patents in these areas have increased and provided an avenue to protect one's intellectual property in this discipline, controversy surrounds the patenting of various technologies in the field. For one, the thought of allowing a company to patent and have a monopoly over a gene sequence that has been around since the beginning of life is quite disturbing. On the other hand, the discovering and developing of a new gene-based pharmaceutical product in the United States requires years of commitment and immense capital resources, possibly in the realm of $500 million. (7) Without the protection of the patent system, these companies would have no means of recouping these capital and time investments, and innovation would be put to a halt. (8)

II. INTELLECTUAL PROPERTY PROTECTION IN GENOMIC DISCIPLINE

Within the genomic discipline, companies and research can be divided into three areas: 1) sequencing the genome, 2) functional genomics, which is finding the functions of the genes, and 3) information systems, which is the software tools that manage and present the tremendous amount of data. Additionally, various biochips technologies, such as micro-arrays, are deployed in cooperation with such genomic tools. For each area, different technology is generated and thus, a different intellectual property strategy should be deployed. Often, companies participate in one or more of the areas and should pursue a joint strategy.

A. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Intellectual Property Strategy in Bioinformatics and Biochips
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.